Eniluracil, also known as GW776 and GW776C85, is an orally active and irreversible inhibitor of dihydropyrimidine dehydrogenase. Eniluracil inhibits dihydropyrimidine dehydrogenase, the rate-limiting enzyme that catabolizes and inactivates 5-fluorouracil (5-FU) in the liver. Co-administration of ethynyluracil permits the oral administration of 5-FU. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).
相关文献及参考
Morcuende, R., et al.: Clin. Translation. Oncol., 9, 459 (2007),
Yen-Revollo, J., et al.: Clin. Cancer Res., 14, 8 (2008),
Spector, T., et al.: Clin. Colorect. Cancer, 9, 52 (2010),
安全信息
Storage condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).